Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165327 · ClinicalTrials.gov registry record · NA
Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction
A NA study, sponsored by University of Texas at Austin.
- Not yet
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT07165327 is a NA study that has not yet begun recruiting, run by University of Texas at Austin. The registered enrollment target is 44 participants.
The verdict
NCT07165327, a NA study, has not yet begun recruiting, sponsored by University of Texas at Austin.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study wants to find out if using an injection port to give insulin during pregnancy helps people take their insulin more regularly and feel better about their care. When someone has diabetes during pregnancy, it's very important to keep their blood sugar levels in a healthy range. This usually means checking blood sugar often and giving insulin through shots. But giving many shots each day can be hard and uncomfortable. An injection port is a small device placed on the skin that lets patients give insulin through the same spot without poking themselves each time. This may make taking insulin easier and less painful. Feeling comfortable with how insulin is given may help people stick to their treatment plan and have better health during pregnancy. Injection ports have already helped other patients, including pregnant people who needed other medications, but they haven't been studied for insulin use during pregnancy. This study will look at how pregnant patients with diabetes feel about using injection ports for insulin.
Interventions
- DEVICE Injection Port for Insulin Administration
- DEVICE Single-Use Insulin Needles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-10 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07165327
The ClinicalTrials.gov registry entry for NCT07165327 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Injection Port for Insulin Administration is the first listed.
NCT07165327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07165327 about?
NCT07165327 is a clinical study titled "Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction". This study wants to find out if using an injection port to give insulin during pregnancy helps people take their insulin more regularly and feel better about their care. When someone has diabetes during pregnancy, it's very important to keep their blood sugar levels in a healthy range. This usually...
What is the current status of trial NCT07165327?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-10. Estimated completion is 2026-10.
What interventions are being tested in trial NCT07165327?
The interventions under investigation include: Injection Port for Insulin Administration (DEVICE), Single-Use Insulin Needles (DEVICE).
Who is sponsoring clinical trial NCT07165327?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.